Atrial fibrillation. Atrial fibrillation and flutter
Conditions
Interventions
Intervention 1: A total of 150 patients 75 in each drug group, enroll in the study.Initiative dose is going to be 25 mg/BD in metoprolol group and will increase according to the patients’ hemodynamic
Prevention
A total of 150 patients 75 in each drug group, enroll in the study.Initiative dose is going to be 25 mg/BD in metoprolol group and will increase according to the patients’ hemodynamic responses.Cardi
A total of 150 patients 75 in each drug group, enroll in the study.Initiative dose is going to be 6.25 daily in carvideloll group and increase according to the patients’ hemodynamic responses.Cardiac
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
21 Years to 81 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients indicated for CABG surgery who did not have any contraindications for beta blocker use .Exclusion criteria: chronic obstructive respiratory failure; advanced AV block; previous AF; bradycardia (HR<60); hypotension (SBP<90); ejection fraction<35%; patients who were undergoing repair or replace of heart valve along with their CABG surgery.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Atrial fibrillation. Timepoint: During the first 5 days after CABG. Method of measurement: Cardiac monitoring. | — |
Secondary
| Measure | Time frame |
|---|---|
| Ventricular fibrillation. Timepoint: During the first 5 days after CABG in ICU. Method of measurement: Cardiac monitoring. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRozita Jalalian
Mazandaran University of Medical Sciences
Outcome results
None listed